Research highlights the cytotoxic activity of selinexor in 3D cultures of pediatric low-grade glioma driven by BRAF(V600E) mutations. This study provides insights into potential therapeutic strategies for this specific tumor type.
cytotoxic activity of selinexor in braf v600e driven pediatric low grade glioma 3d cultures
Original title: “Cytotoxic activity of selinexor in BRAF(V600E)-driven pediatric low-grade glioma 3D cultures.”